COVID-19 recoveries exceed active cases by 98,493: Health Ministry Data

The number of active cases stood at 1,97,387 while 2,95,880 patients have recovered, the ministry said, adding, "With this encouraging status, the recovery rate is touching 58.13 percent amongst COVID-19 patients."

PTI

June 27, 2020 / 09:12 PM IST

The total number of recoveries has fast outgrown the number of active COVID-19 cases, with the difference between the two nearing one lakh fast, the Union health ministry said on Saturday. The recovered cases have exceeded the active cases by 98,493 as of Saturday.

The number of active cases stood at 1,97,387 while 2,95,880 patients have recovered, the ministry said, adding, "With this encouraging status, the recovery rate is touching 58.13 percent amongst COVID-19 patients."

India's COVID-19 tally raced past the five-lakh mark on Saturday with the biggest single-day surge of 18,552 cases, while the death toll climbed to 15,685 with 384 fatalities.

Coronavirus India News LIVE Updates

According to the Indian Council of Medical Research (ICMR), a cumulative total of 79,96,707 samples have been tested up to June 26 with 2,20,479 samples being tested on Friday, the highest in a day since the beginning of the pandemic.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show